H.R. 3752 (119th)Bill Overview

Specialist Fourth Class Keith Smith Glioblastoma Parity Act of 2025

Armed Forces and National Security|Armed Forces and National Security
Cosponsors
Support
Bipartisan
Introduced
Jun 5, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Veterans' Affairs.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill adds glioblastoma multiforme to the list of diseases for which veterans who served in certain locations during the Vietnam era are presumed to have a service connection under 38 U.S.C. 1116(a)(2). The text includes findings about Agent Orange and herbicide spraying in Vietnam and neighboring areas.

Why people may split

Liberal emphasizes veterans' justice and prompt benefits access

Watch point

Relative to its intended legislative type, this bill is a concise substantive amendment that directly inserts 'Glioblastoma multiforme' into the statutory list of diseases presumed service-connected under 38 U.S.C. §1116(a)(2).

The bill adds glioblastoma multiforme to the list of diseases for which veterans who served in certain locations during the Vietnam era are presumed to have a service connection under 38 U.S.C. 1116(a)(2).

The text includes findings about Agent Orange and herbicide spraying in Vietnam and neighboring areas.

No additional administrative or funding details are specified in the bill text.

Passage40/100

Narrow, sympathetic veterans measure with fiscal implications; historically plausible but subject to cost review and Senate process.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a concise substantive amendment that directly inserts 'Glioblastoma multiforme' into the statutory list of diseases presumed service-connected under 38 U.S.C. §1116(a)(2).

Contention30/100

Liberal emphasizes veterans' justice and prompt benefits access

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
VeteransFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • VeteransIncreases veterans’ access to VA disability compensation and health care for glioblastoma without proving direct servic…
  • VeteransReduces evidentiary burden, simplifying claims and speeding benefit approvals for eligible Vietnam-era veterans.
  • Potential benefitMay decrease appeals and litigation by establishing a clear presumption of service connection.
Likely burdened
  • Federal agenciesIncreases federal VA expenditures for disability compensation and medical care, raising budgetary demands.
  • Federal agenciesMay set a precedent for adding additional conditions, expanding long-term federal liabilities for toxic exposures.
  • Potential burdenAmbiguity about eligible locations and service records could increase administrative complexity and processing delays.
03 · Why people split

Why the argument around this bill splits.

Liberal emphasizes veterans' justice and prompt benefits access
Progressive95%

This persona will likely strongly support the bill as a targeted veterans health benefit addressing Agent Orange harms.

They view presumptive service connection as a necessary remedy for exposure-related cancers and a correction of historical neglect.

They may urge swift passage and broad application to affected veterans and families.

Leans supportive
Centrist85%

A pragmatic centrist will generally support expanding presumptions for veterans but want clearer details.

They will ask for cost estimates, implementation guidance, and the scientific basis linking glioblastoma to herbicide exposure.

They will favor compromises that ensure efficient VA processing and fiscal transparency.

Leans supportive
Conservative70%

Mainstream conservatives sympathetic to veterans may cautiously support the measure, but will express concern about expanding presumptions without strong, established scientific causal links.

They will also worry about the fiscal and administrative burden on the VA and potential precedent for further expansions.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Narrow, sympathetic veterans measure with fiscal implications; historically plausible but subject to cost review and Senate process.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Magnitude of VA cost increase (CBO estimate absent)
  • Strength of underlying scientific evidence linking glioblastoma to exposure
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberal emphasizes veterans' justice and prompt benefits access

Narrow, sympathetic veterans measure with fiscal implications; historically plausible but subject to cost review and Senate process.

Unlocked analysis

Relative to its intended legislative type, this bill is a concise substantive amendment that directly inserts 'Glioblastoma multiforme' into the statutory list of diseases presumed service-connected under 38 U.S.C. §111…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis